MICHELLE VANDERPOOL: Open Payments
NPI 1477224426 · WASILLA, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 13 payments from 5 companies in 2025. Trend: 2023 $676 · 2024 $465 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $120 |
| GlaxoSmithKline, LLC. | 5 | $111 |
| Xeris Pharmaceuticals, Inc. | 3 | $75 |
| Lundbeck LLC | 1 | $23 |
| PFIZER INC. | 1 | $20 |
Products named: TRELEGY ELLIPTA, GVOKE HYPOPEN, FASENRA, AIRSUPRA, SHINGRIX, REXULTI, PAXLOVID.
Industry payments across AK — which companies pay providers there.
